Hospital
Daviess County Hospital
Daviess County Hospital was paid $9.36M by Medicaid between Jan 2018 and Nov 2024, across 107 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoDAVIESS COUNTY HOSPITAL
WASHINGTON, IN 47501
WASHINGTON, IN 47501
33aNPI1861465999assigned 02/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.36M
24GClaims264,064
24DCodes billed107
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#36 of 69
Median peer was paid$9.76M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,184 | $496K | |
| 2019 | 27,810 | $747K | |
| 2020 | 22,165 | $649K | |
| 2021 | 39,194 | $1.55M | |
| 2022 | 51,620 | $2.23M | |
| 2023 | 46,881 | $2.08M | |
| 2024incomplete | 35,210 | $1.61M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 14,628 | 12,668 | $2.12M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 9,898 | 8,322 | $1.59M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 7.9% | 9,741 | 8,879 | $742K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.5% | 16,540 | 14,822 | $702K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.6% | 4,710 | 3,651 | $619K |
| 71045 | Radiologic examination, chest; single view | 4.8% | 4,054 | 3,258 | $446K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.2% | 9,653 | 9,083 | $298K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.1% | 2,336 | 2,085 | $294K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.1% | 5,150 | 4,026 | $290K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.7% | 609 | 268 | $250K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.5% | 1,588 | 571 | $235K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 2.5% | 2,735 | 1,697 | $235K |
95 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.9% | 2,250 | $178K |
| 80053 | Comprehensive metabolic panel | 1.6% | 31,303 | $152K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.5% | 2,095 | $143K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.3% | 1,525 | $125K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 33,713 | $114K |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.1% | 1,270 | $101K |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 1,557 | $79K |
| 36415 | Collection of venous blood by venipuncture | <1% | 45,992 | $74K |
| 87634 | <1% | 866 | $49K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,291 | $41K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 510 | $35K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 424 | $33K |
| 80061 | Lipid panel | <1% | 4,168 | $31K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 463 | $31K |
| 84484 | <1% | 5,147 | $27K | |
| 59025 | Fetal non-stress test | <1% | 130 | $26K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 242 | $26K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,535 | $24K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 257 | $22K |
| 81001 | <1% | 11,656 | $20K | |
| Q3014 | Telehealth originating site facility fee | <1% | 309 | $18K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 48 | $18K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,624 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 212 | $13K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 810 | $12K |
| 83605 | <1% | 2,045 | $12K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 125 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 303 | $9K |
| 80306 | <1% | 739 | $8K | |
| 84145 | <1% | 670 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,595 | $8K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 35 | $7K |
| 81025 | <1% | 1,252 | $7K | |
| 83880 | <1% | 371 | $6K | |
| 83735 | <1% | 1,969 | $5K | |
| 82607 | <1% | 634 | $5K | |
| 82550 | <1% | 1,822 | $5K | |
| 97597 | <1% | 38 | $5K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 323 | $5K |
| 83690 | <1% | 1,086 | $3K | |
| 84100 | <1% | 1,340 | $3K | |
| 84439 | <1% | 632 | $2K | |
| 83655 | <1% | 195 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 107 | $2K |
| 87040 | <1% | 558 | $2K | |
| 97165 | <1% | 51 | $2K | |
| 97161 | <1% | 43 | $2K | |
| 82553 | <1% | 866 | $2K | |
| 85610 | <1% | 789 | $2K | |
| 82043 | <1% | 479 | $2K | |
| 86756 | <1% | 127 | $1K | |
| 36416 | <1% | 244 | $967.83 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 119 | $909.33 |
| 87081 | <1% | 313 | $767.69 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 54 | $766.25 |
| 82746 | <1% | 133 | $759.99 | |
| G0378 | Hospital observation service, per hour | <1% | 216 | $757.73 |
| 83540 | <1% | 164 | $753.36 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 67 | $601.02 |
| 81003 | <1% | 297 | $584.89 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 643 | $519.14 |
| 82728 | <1% | 50 | $490.81 | |
| 85379 | <1% | 114 | $474.52 | |
| 87070 | <1% | 46 | $464.90 | |
| 80069 | <1% | 153 | $441.63 | |
| 81000 | <1% | 655 | $411.10 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,375 | $404.18 |
| 82948 | <1% | 153 | $364.83 | |
| 86140 | <1% | 140 | $355.59 | |
| 82150 | <1% | 200 | $343.28 | |
| 85652 | <1% | 258 | $325.48 | |
| 85730 | <1% | 145 | $279.77 | |
| 87077 | <1% | 57 | $224.67 | |
| 84436 | <1% | 25 | $171.75 | |
| 83550 | <1% | 33 | $168.70 | |
| 84479 | <1% | 25 | $161.75 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 203 | $142.80 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 44 | $73.71 |
| 82570 | <1% | 40 | $71.37 | |
| 87186 | <1% | 15 | $60.55 | |
| 86308 | <1% | 21 | $12.40 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,864 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 127 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 43 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 61 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 25 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 47 | $0.00 |
| 96376 | 0% | 21 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 15 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 29 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 19 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 2,346 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 194 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 14 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHOWALTER, ANOTHY (PRESIDENT OF BOARD OF DIRECTORS)